Andres Tellez

Sr. Director, NewCo Development

  • Focus: All sectors (Pharmaceutical, medical device, consumer and digital health)
  • Based in Cambridge, MA/span>
  • Fun Fact: Lived in Japan for 2 years

Andres Tellez is the Sr. Director, NewCo Development, where he is responsible for the creation and launch of newly defined companies aligned with the strategic needs of Johnson & Johnson.

Prior to joining JJDC, Andres served as a Executive Director, Business Development and Strategy and was a founding member of the leadership team at Cedilla Therapeutics, a Third Rock Ventures portfolio company. In this role Andres was responsible for business operations and strategy and played an integral role in securing the company’s $82.6M Series B. In addition, Andres led the negotiation of all partnerships essential to establishing the company’s drug discovery funnel for precision oncology, including sponsored research collaborations, DNA Encoded Library and high throughput screening deals, proteomics, biochemical and biophysics collaborations.

Before Cedilla, Andres was Senior Director, Business Development at Syros Pharmaceuticals where he negotiated and closed a target discovery deal with the Incyte Corporation, a clinical supply agreement with Janssen Research and Development, LLC and a supported a PIPE. Before joining Syros, Andres worked for several years at Cerulean Pharma, rising to Director and acting head of business development. At Cerulean he served in a broad role, negotiating strategic collaborations with Novartis, AstraZeneca and the NCI and supporting the company’s clinical development. He also directly supported fundraising efforts, including the IPO and follow-on offering.

Earlier in his career Andres was a consultant at C1 Consulting and worked on market research and competitive landscape assessment projects for market leading programs in solid tumor oncology.

Andres received his Bachelor of Science and Master of Engineering degrees in Electrical Engineering and Computer Science from MIT. In addition, he holds a PhD in Bioinformatics from Stanford University.

Andres Tellez
Andres Tellez